pirinixic acid has been researched along with Carcinoma, Renal Cell in 1 studies
pirinixic acid: structure
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, R | 3 |
| Zhao, J | 3 |
| Jin, J | 3 |
| Tian, Y | 3 |
| Lan, L | 3 |
| Wang, X | 3 |
| Zhu, L | 3 |
| Wang, J | 3 |
1 other study available for pirinixic acid and Carcinoma, Renal Cell
| Article | Year |
|---|---|
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC.
Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm | 2022 |
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC.
Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm | 2022 |
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC.
Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm | 2022 |
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC.
Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm | 2022 |
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC.
Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm | 2022 |
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC.
Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm | 2022 |
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC.
Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm | 2022 |
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC.
Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm | 2022 |
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC.
Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm | 2022 |